Home/Filings/4/0001562180-16-002785
4//SEC Filing

BIO-TECHNE Corp 4

Accession 0001562180-16-002785

$TECHCIK 0000842023operating

Filed

Jul 11, 8:00 PM ET

Accepted

Jul 12, 5:33 PM ET

Size

9.3 KB

Accession

0001562180-16-002785

Insider Transaction Report

Form 4
Period: 2016-07-09
Gould Kevin S
SVP Clinical Controls
Transactions
  • Tax Payment

    Common Stock

    2016-07-09$115.17/sh309$35,5882,191 total
Holdings
  • Stock Options (Right to buy)

    Exercise: $97.23Exp: 2022-07-09Common Stock (50,000 underlying)
    50,000
  • Stock Options (Right to buy)

    Exercise: $97.23Exp: 2022-07-09Common Stock (15,000 underlying)
    15,000
  • Stock Options (Right to buy)

    Exercise: $88.23Exp: 2023-01-04Common Stock (10,000 underlying)
    10,000
Footnotes (5)
  • [F1]1. The reporting person has elected to satisfy his tax withholding obligation in connection with the vesting of a prior restricted stock unit gran by directing the Company to withhold shares otherwise issuable pursuant to the previously reported grant.
  • [F2]2. Includes 833 shares of restricted stock units that vest on 7/9/17 and 834 shares of restricted stock units that vest on 7/9/18.
  • [F3]4. 50,000 common stock options vest if certain performance goals are achieved for the 12 months ending 05/31/2018.
  • [F4]3. Vests as to 3,750 shares on each of 07/09/16, 07/09/17, 07/09/18 and 07/09/19.
  • [F5]5. Vests as to 2,500 shares on each of 01/04/2017, 01/04/2018, 01/04/2019 and 01/04/2020.

Issuer

BIO-TECHNE Corp

CIK 0000842023

Entity typeoperating
IncorporatedMN

Related Parties

1
  • filerCIK 0000842023

Filing Metadata

Form type
4
Filed
Jul 11, 8:00 PM ET
Accepted
Jul 12, 5:33 PM ET
Size
9.3 KB